Your browser doesn't support javascript.
loading
Durability of Cross-Neutralizing Antibodies 5.5 Months After Bivalent Coronavirus Disease 2019 Vaccine Booster.
Rössler, Annika; Knabl, Ludwig; Netzl, Antonia; Bante, David; Borena, Wegene; von Laer, Dorothee; Smith, Derek J; Kimpel, Janine.
Afiliação
  • Rössler A; Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria.
  • Knabl L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Netzl A; Tyrolpath Obrist Brunhuber GmbH, Zams, Austria.
  • Bante D; Centre for Pathogen Evolution, Department of Zoology, University of Cambridge, United Kingdom.
  • Borena W; Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria.
  • von Laer D; Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria.
  • Smith DJ; Institute of Virology, Department of Hygiene, Microbiology and Public Health, Medical University of Innsbruck, Austria.
  • Kimpel J; Centre for Pathogen Evolution, Department of Zoology, University of Cambridge, United Kingdom.
J Infect Dis ; 229(3): 644-647, 2024 Mar 14.
Article em En | MEDLINE | ID: mdl-38016020
ABSTRACT
We analyzed neutralizing antibodies in samples from ancestral + BA.1 and ancestral + BA.4/5 boosted individuals, collected around 5.5 months after booster. Titers of neutralizing antibodies generally decreased compared to a time point early after the bivalent booster immunization. This was more pronounced for individuals without infection history and for recently emerged Omicron variants.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article